{"database": "openregs", "table": "documents", "rows": [["FDA-1999-D-0081-0004", "FDA", "FDA-1999-D-0081", "Testing of Retroviral Vector-Based Human Gene Therapy Products for\nReplication Competent Retrovirus During Product Manufacture and\nPatient Follow-up; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2018-07-12T04:00:00Z", 2018, 7, "2018-07-12T04:00:00Z", null, "2018-07-12T17:26:33Z", "2018-14868", 0, 0, "09000064834d7d00"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1999-D-0081-0004"], "units": {}, "query_ms": 22.213171992916614, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}